121 related articles for article (PubMed ID: 26272850)
1. Cosolvency approach for assessing the solubility of drugs in poly(vinylpyrrolidone).
Chen X; Fadda HM; Aburub A; Mishra D; Pinal R
Int J Pharm; 2015 Oct; 494(1):346-56. PubMed ID: 26272850
[TBL] [Abstract][Full Text] [Related]
2. A method to predict the equilibrium solubility of drugs in solid polymers near room temperature using thermal analysis.
Bellantone RA; Patel P; Sandhu H; Choi DS; Singhal D; Chokshi H; Malick AW; Shah N
J Pharm Sci; 2012 Dec; 101(12):4549-58. PubMed ID: 22987330
[TBL] [Abstract][Full Text] [Related]
3. A novel method for determining the solubility of small molecules in aqueous media and polymer solvent systems using solution calorimetry.
Fadda HM; Chen X; Aburub A; Mishra D; Pinal R
Pharm Res; 2014 Jul; 31(7):1735-43. PubMed ID: 24554115
[TBL] [Abstract][Full Text] [Related]
4. Influence of Polymer Molecular Weight on Drug-Polymer Solubility: A Comparison between Experimentally Determined Solubility in PVP and Prediction Derived from Solubility in Monomer.
Knopp MM; Olesen NE; Holm P; Langguth P; Holm R; Rades T
J Pharm Sci; 2015 Sep; 104(9):2905-12. PubMed ID: 25740567
[TBL] [Abstract][Full Text] [Related]
5. The Influence of PVP Polymer Topology on the Liquid Crystalline Order of Itraconazole in Binary Systems.
Orszulak L; Lamrani T; Bernat R; Tarnacka M; Żakowiecki D; Jurkiewicz K; Zioła P; Mrozek-Wilczkiewicz A; Zięba A; Kamiński K; Kamińska E
Mol Pharm; 2024 Jun; 21(6):3027-3039. PubMed ID: 38755753
[TBL] [Abstract][Full Text] [Related]
6. Levitated single-droplet drying: case study with itraconazole dried in binary organic solvent mixtures.
Wulsten E; Kiekens F; van Dycke F; Voorspoels J; Lee G
Int J Pharm; 2009 Aug; 378(1-2):116-21. PubMed ID: 19501641
[TBL] [Abstract][Full Text] [Related]
7. Influence of PVP/VA copolymer composition on drug-polymer solubility.
Rask MB; Knopp MM; Olesen NE; Holm R; Rades T
Eur J Pharm Sci; 2016 Mar; 85():10-7. PubMed ID: 26826280
[TBL] [Abstract][Full Text] [Related]
8. Theoretical and experimental investigation on the solid solubility and miscibility of naproxen in poly(vinylpyrrolidone).
Paudel A; Van Humbeeck J; Van den Mooter G
Mol Pharm; 2010 Aug; 7(4):1133-48. PubMed ID: 20524682
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
Xiang TX; Anderson BD
J Pharm Sci; 2013 Mar; 102(3):876-91. PubMed ID: 23280486
[TBL] [Abstract][Full Text] [Related]
10. Unexpected solvent impact in the crystallinity of praziquantel/poly(vinylpyrrolidone) formulations. A solubility, DSC and solid-state NMR study.
Costa ED; Priotti J; Orlandi S; Leonardi D; Lamas MC; Nunes TG; Diogo HP; Salomon CJ; Ferreira MJ
Int J Pharm; 2016 Sep; 511(2):983-93. PubMed ID: 27506511
[TBL] [Abstract][Full Text] [Related]
11. The effect of polymeric additives on the solubilisation of a poorly-soluble drug in micellar solutions of Pluronic F127.
Oliveira CP; Vasconcellos LC; Ribeiro ME; Ricardo NM; Souza TV; Costa Fde M; Chaibundit C; Yeates SG; Attwood D
Int J Pharm; 2011 May; 409(1-2):206-8. PubMed ID: 21354466
[TBL] [Abstract][Full Text] [Related]
12. Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation.
Nair R; Nyamweya N; Gönen S; Martínez-Miranda LJ; Hoag SW
Int J Pharm; 2001 Aug; 225(1-2):83-96. PubMed ID: 11489557
[TBL] [Abstract][Full Text] [Related]
13. Comparative Study of Different Methods for the Prediction of Drug-Polymer Solubility.
Knopp MM; Tajber L; Tian Y; Olesen NE; Jones DS; Kozyra A; Löbmann K; Paluch K; Brennan CM; Holm R; Healy AM; Andrews GP; Rades T
Mol Pharm; 2015 Sep; 12(9):3408-19. PubMed ID: 26214347
[TBL] [Abstract][Full Text] [Related]
14. Solubility enhancement of hydrophobic compounds by cosolvents: role of solute hydrophobicity on the solubilization effect.
Miyako Y; Khalef N; Matsuzaki K; Pinal R
Int J Pharm; 2010 Jun; 393(1-2):48-54. PubMed ID: 20363302
[TBL] [Abstract][Full Text] [Related]
15. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
[TBL] [Abstract][Full Text] [Related]
16. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation.
Van Eerdenbrugh B; Taylor LS
Mol Pharm; 2010 Aug; 7(4):1328-37. PubMed ID: 20536263
[TBL] [Abstract][Full Text] [Related]
17. Application of film-casting technique to investigate drug-polymer miscibility in solid dispersion and hot-melt extrudate.
Parikh T; Gupta SS; Meena AK; Vitez I; Mahajan N; Serajuddin AT
J Pharm Sci; 2015 Jul; 104(7):2142-52. PubMed ID: 25917333
[TBL] [Abstract][Full Text] [Related]
18. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
[TBL] [Abstract][Full Text] [Related]
19. Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions.
Crowley KJ; Zografi G
J Pharm Sci; 2002 Oct; 91(10):2150-65. PubMed ID: 12226842
[TBL] [Abstract][Full Text] [Related]
20. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
